This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked SENP3 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SENP3 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~65 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A04474Y24 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | C6 (40ug), NIH-3T3 (40ug), Hela (40ug), COS-7 (40ug) (catalog A04474Y24) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A04474Y24; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
SENP3 is predicted at 65 kDa; phosphorylation could affect migration, but no empirical band size or visible shift is established.
| Single band near 65 kDa | consistent with the predicted SENP3 mass; identity requires a control |
| Faint band near 65 kDa | SENP3 may be underrepresented if nuclear protein extraction is poor |
| No band near 65 kDa | nuclear extraction or detection may be inadequate |
| Nearby doublet around 65 kDa | SENP3 has documented phosphorylation sites, but distinct band migration is unproven |
| Predicted mass of 65 kDa | sets the reference size; migration has not been measured here |
| Phosphoserine 54 | could affect migration, but no visible shift is established |
| Phosphoserines 73 and 75 | could affect migration, but no visible shift is established |
| Phosphothreonine 176 | could affect migration, but no visible shift is established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | nuclear SENP3 may be poorly recovered | check nuclear extraction and a nuclear protein control |
| Weak or no signal | low SENP3 recovery or inadequate detection | check loading, transfer and antibody detection |
| Band higher than expected | the supplied features do not establish the cause of a large shift | confirm identity with SENP3 depletion or an independent antibody |
| Band lower than expected | the supplied features do not establish a smaller SENP3 form | confirm identity with SENP3 depletion or an independent antibody |
| Multiple bands | phosphorylation is documented, but distinct migrating forms are unproven | compare bands after SENP3 depletion |
| Fragments below expected size | sample degradation is possible | prepare fresh lysate with protease inhibitors and check band identity |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Medium | Protein (IHC) | HPA → |
| Caudate | neuronal cells | Medium | Protein (IHC) | HPA → |
| Cervix | glandular cells | Medium | Protein (IHC) | HPA → |
| Esophagus | squamous epithelial cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Lung | alveolar cells | Not detected | Protein (IHC) | HPA → |
| Lymph node | germinal center cells | Not detected | Protein (IHC) | HPA → |
| Ovary | follicle cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for SENP3, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-SENP3 antibody, A04474Y24, with reported Human, Mouse, and Rat reactivity. Its WB image shows C6, NIH-3T3, HeLa, and COS-7 whole-cell lysates at 1:500 and 40 µg per lane. Evidence is limited to the shown conditions.
Which to pick: A04474Y24 is the only listed option and has a WB image. Check its reported reactivity against your sample; the pictured lysates and 1:500 dilution provide tested starting contexts, not validation of every sample or condition.